Aromatic Wentong for heart small vessel disease
Part of Heart & circulation clinical trials.
This trial tests a Chinese herbal medicine called Aromatic Wentong for people with coronary microvascular disease—a condition where the tiny blood vessels in the heart don't work properly, causing chest pain. The medicine may help improve blood flow in the small vessels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 80 years old.
- Have symptoms of heart ischemia (e.g., chest pain) confirmed by tests like ECG or stress test.
- Have a heart catheterization showing at least 50% narrowing in a major heart artery, but additional measurements show your small heart vessels are not working well.
- Have not taken any Chinese herbal medicine for at least two weeks before starting the trial.
- Not have severe liver or kidney problems, severe heart conditions, or be pregnant/nursing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a Chinese herbal pill called Qishenyiqi can help people with chest pain caused by tiny heart blood vessels that are too tight. It may be an option if standard tests show your heart vessels are mostly clear but your blood flow is reduced.
This trial tests whether a small pressure-reducing device placed in a heart vein (the coronary sinus) can reduce symptoms in people with ongoing chest pain from tiny blood vessel problems. It is for angina that has not improved despite standard heart medicines, and only if special heart tests show reversible reduced blood flow.
This study looks at chest pain caused by tiny blood vessels in the heart that don't show up on standard angiograms. It aims to understand this condition better to help find better care.
This trial tests whether traditional Chinese medicine can help elderly patients with coronary heart disease who still have chest pain or discomfort despite standard treatments. It focuses on those who cannot have or have not fully benefited from procedures like stents or bypass surgery.
This trial tests whether Xuesaitong soft capsules can improve major risk factors in people with stable coronary heart disease who are already on cholesterol-lowering and antiplatelet medications. You may be able to join if you have chronic coronary artery disease and certain signs of inflammation.
This trial tests a traditional Chinese herbal formula, Tanhuo Decoction, for elderly patients who recently had a heart attack (acute coronary syndrome) and also have brain artery narrowing or a history of stroke. It aims to see if the medicine helps improve recovery and reduce future risks.
Hear when a new Coronary Microvascular Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.